Used in scientific research as a selective α7 nicotinic acetylcholine receptor partial agonist. It is primarily investigated for its potential cognitive-enhancing properties, particularly in models of schizophrenia and Alzheimer’s disease. Studies suggest it may improve attention, memory, and sensory gating deficits in preclinical models. Due to its action on central nervous system receptors, it serves as a tool compound for understanding cholinergic neurotransmission and developing novel treatments for neuropsychiatric disorders. Not intended for human therapeutic use and is restricted to laboratory and experimental applications.